A Noninferiority Trial Comparing 2 Days vs 5 Days of Terlipressin and Ceftriaxone in Terms of 5-Day Rebleeding for Patients With Acute Gastroesophageal Variceal Hemorrhage.
Gin-Ho LoJen-Hao YehCheng-Hao TsengTzu-Haw ChenChi-Ming TaiWen-Lun WangHui-Chen LinPublished in: The American journal of gastroenterology (2024)
After successful endoscopic hemostasis of acute variceal bleeding, combination of 2-day terlipressin infusion and ceftriaxone therapy was not inferior to the 5-day regimen in terms of very early rebleeding, with the advantage of shortening hospitalization stay.
Keyphrases
- liver failure
- respiratory failure
- ultrasound guided
- study protocol
- phase iii
- atrial fibrillation
- low dose
- clinical trial
- phase ii
- drug induced
- aortic dissection
- stem cells
- mesenchymal stem cells
- intensive care unit
- extracorporeal membrane oxygenation
- endoscopic submucosal dissection
- acute respiratory distress syndrome
- replacement therapy